Home > Research > Publications & Outputs > Cost-effectiveness of dabigatran etexilate for ...
View graph of relations

Cost-effectiveness of dabigatran etexilate for the primary prevention of venous thromboembolism in total hip and knee replacement in Portugal

Research output: Contribution to Journal/MagazineMeeting abstractpeer-review

Published

Standard

Cost-effectiveness of dabigatran etexilate for the primary prevention of venous thromboembolism in total hip and knee replacement in Portugal. / Caixeiro Mateus, Ceu; Wolowacz, S.; Pereira, J. A.
In: Value in Health, Vol. 12, No. 3, 05.2009, p. A148-A148.

Research output: Contribution to Journal/MagazineMeeting abstractpeer-review

Harvard

APA

Vancouver

Author

Bibtex

@article{1a4af097522f4d02a4d1f44843397998,
title = "Cost-effectiveness of dabigatran etexilate for the primary prevention of venous thromboembolism in total hip and knee replacement in Portugal",
author = "{Caixeiro Mateus}, Ceu and S. Wolowacz and Pereira, {J. A.}",
year = "2009",
month = may,
doi = "10.1016/S1098-3015(10)73801-8",
language = "English",
volume = "12",
pages = "A148--A148",
journal = "Value in Health",
issn = "1098-3015",
publisher = "ELSEVIER SCIENCE INC",
number = "3",

}

RIS

TY - JOUR

T1 - Cost-effectiveness of dabigatran etexilate for the primary prevention of venous thromboembolism in total hip and knee replacement in Portugal

AU - Caixeiro Mateus, Ceu

AU - Wolowacz, S.

AU - Pereira, J. A.

PY - 2009/5

Y1 - 2009/5

U2 - 10.1016/S1098-3015(10)73801-8

DO - 10.1016/S1098-3015(10)73801-8

M3 - Meeting abstract

VL - 12

SP - A148-A148

JO - Value in Health

JF - Value in Health

SN - 1098-3015

IS - 3

ER -